Peptide Drugs intermediate
Goserelin: Oligopeptide Research Reference
Sustained-release GnRH agonist depot for prostate cancer, endometriosis, and breast cancer. This peptide or oligopeptide is studied for its biological activi...
By Encyclopeptide Editorial | 1 min read
gnrh agonist prostate-cancer
Overview
Sustained-release GnRH agonist depot for prostate cancer, endometriosis, and breast cancer.
Structure
| Property | Value |
|---|---|
| Name | Goserelin |
Mechanism of Action
Biodegradable depot provides sustained GnRH receptor activation suppressing gonadotropins.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | Goserelin |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about Goserelin: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept